The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification

AUTOR(ES)

Pinder, Sarah E

FONTE

BioMed Central

RESUMO

Intraductal epithelial proliferations of the breast are at present classified into three groups; distinction is made histologically and clinically between usual epithelial hyperplasia and atypical ductal hyperplasia (ADH) and between ADH and ductal carcinoma in situ (DCIS). Although evidence indicates that these boundaries are not ideal on a morphological, immunohistochemical, or genetic basis, this three-tier system is accepted and used at present. The current definitions, histological features, and system of classification of ADH and DCIS are described in this manuscript.

Documentos Relacionados

• The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
• The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions
• The diagnosis and management of pre-invasive breast disease: Problems associated with management of pre-invasive lesions
• The diagnosis and management of pre-invasive breast disease: Promise of new technologies in understanding pre-invasive breast lesions
• The diagnosis and management of pre-invasive breast disease: Radiological diagnosis